[Vagina cytological screening--follow up of unsatisfactory specimens].
During the screening of vaginal cytological samples to determine the pre-stages of cervical cancer, some samples cannot be evaluated, usually as a result of the presence of inflammatory cells. In this study, we compare the clinical handling of these samples at two cytology laboratories at the Norra Alvsborgs Hospital, NAL, in Trollhättan, Sweden and the Södra Alvsborgs Hospital, SAS, in Borås, Sweden. We also present a follow-up of the women involved. At the NAL, the women were treated with anti-inflammatory drugs and new samples were then taken after three months. At the SAS, on the other hand, new samples were simply taken after the next menstruation. The results indicate that no differences can be seen when it comes to the ease of evaluation.
Matusik
Janusz
J
Laboratoriet för klinisk cytologi, Södra Alvsborgs sjukhus, Borås. janusz.matusik@vgregion.se
Andréasson
Jan
J
Olofsson
Kenth
K
Nielsen
Thorkild
T
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017064:Process Assessment, Health Care; D013048:Specimen Handling / Q000379:methods / Q000592:standards; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000517:prevention & control; D014626:Vaginal Smears / Q000379:methods / Q000592:standards; D014627:Vaginitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D016585:Vaginosis, Bacterial / Q000150:complications / Q000188:drug therapy / Q000473:pathology
D000893:Anti-Inflammatory Agents